导航

| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -19.30% | 4326/4773 |
| 近一周 | -3.47% | 4211/5462 |
| 近一月 | -10.42% | 5068/5421 |
| 近一季 | -21.54% | 5058/5209 |
| 近半年 | -21.12% | 4432/4920 |
| 近一年 | -10.65% | 3437/4366 |
| 近两年 | 60.89% | 1189/2954 |
| 近三年 | 15.40% | 1626/2253 |
| 成立以来 | 137.85% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-0.97% 2039/4961 |
0.66% 3147/5312 |
- - |
- - |
| 2025 | 53.71% 377/4813 |
6.49% 625/3635 |
-0.80% 3031/4076 |
47.34% 467/4524 |
-1.25% 2883/4813 |
| 2024 | 1.11% 2026/3463 |
-6.83% 2085/2808 |
-9.51% 2371/3014 |
21.78% 550/3129 |
-1.52% 1739/3463 |
| 2023 | -25.99% 1984/2656 |
-1.88% 1898/2280 |
-5.19% 1397/2385 |
-14.80% 2197/2515 |
-6.62% 1851/2655 |
| 2022 | -26.70% 1424/2207 |
-16.01% 1093/1919 |
19.49% 86/2016 |
-22.80% 1935/2113 |
-5.39% 1927/2208 |
| 2021 | 39.39% 36/1822 |
-10.88% 1120/1255 |
41.05% 18/1330 |
12.21% 100/1466 |
-1.18% 1324/1822 |
| 2020 | - - |
- - |
- - |
13.02% 347/1164 |
45.48% 9/1184 |
| 2019 | - - |
- - |
- - |
- - |
- - |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 万家中证港股通创新药ETF | 1.5896 | 28.31% |
| 景顺长城中证港股通创新药ETF | 1.6507 | 28.23% |
| 港股医疗 | 0.9366 | 28.18% |
| 港股医疗ETF | 1.4282 | 28.15% |
| 港股通医疗ETF工银 | 0.9464 | 28.06% |
| 港股通医疗ETF华宝 | 0.9577 | 27.97% |
| 天弘恒生沪深港创新药精选50ETF发起联接C | 1.2844 | 27.92% |
| 天弘恒生沪深港创新药精选50ETF | 0.8437 | 27.35% |
| 万家中证港股通创新药ETF发起式联接A | 1.3863 | 27.32% |
| 万家中证港股通创新药ETF发起式联接C | 1.3856 | 27.27% |
| 国泰中证新能源汽车ETF联接A VS. 长安沪深300非周期A(740101) |